Definitive Contract HHSO100201600028C

Award Date 8/25/16
Potential Completion Date 6/30/19
Potential Value $5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fountain Hill, PA 18015, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $5,746,950.00 firm-fixed-price definitive contract to Orasure Technologies Inc. for the delivery of over-the-counter (OTC) COVID-19 tests. The contract has a performance period through March 19, 2025 and was not set aside for any special business designation. Orasure, a manufacturer of diagnostic products including rapid tests for HIV, Ebola, and COVID-19, has been a...
This federal contract award to Orasure Technologies Inc. (Orasure), a manufacturer of diagnostic products, modifies the OraQuick test platform to enable antigen detection of the Ebola Zaire virus for use with various sample types. The contract, awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, has a ceiling value of $11,937,826.99 and will run through August 31, 2022. Orasure holds two significant indefinite delivery...
Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $540,609 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this firm fixed price contract, Orasure will conduct research and development of an antibody test to support the Coronavirus COVID-19 National Interest Action Code and COVID-19 - R & D OF A RAPID ANTIGEN TEST major program. Performance will take place in Fountain...
Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $78.1 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The firm fixed price contract is for COVID 19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASE EXPANSION and will support the expansion of Orasure's COVID-19 home test production capacity through March 2024. Performance will take place in...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $7,048,087.00 firm fixed price contract to Orasure Technologies Inc. (doing business as Orasure) for the provision of INTELISWAB COVID-19 rapid tests. This contract was set aside exclusively for small businesses and has a period of performance through April 30, 2024. The original solicitation, issued by the Biomedical Advanced Research and Development Authority (BARDA)...
The U.S. Department of Health and Human Services (HHS) awarded a $240,491.71 firm-fixed-price purchase order to OraSure Technologies Inc. (doing business as OraSure) for the acquisition of Filovirus Point-of-Care (POC) diagnostic tests. The award, which has no set-aside designation, supports the procurement of a minimum of 8,500 lateral flow, rapid antigen tests for Ebola virus that can be used on oral fluids from cadavers and have a nine-month shelf life. OraSure is the only current provider...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $30.88 million definitive contract to Orasure Technologies Inc., doing business as Orasure, to provide COVID-19 home test industrial base expansion transitioning from the Department of Defense/Air Force to HHS/ASPR. The contract is for COVID-19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASED EXPANSION TRANSITIONING FROM THE DOD/AF TO HHS/ASPR under Department...
This federal contract award, valued at $388,440,000.00, was issued by the Defense Logistics Agency Troop Support Medical to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products. The contract is for the delivery of InteliSwab COVID-19 Rapid Test Kits, a type of over-the-counter COVID-19 diagnostic test. The contract has an ultimate completion date of October 6, 2022 and was awarded on October 20, 2021. No set-aside designation was used for this contract....
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. to develop improvements to the OraQuick Ebola Rapid Antigen Test. The $15,504,106.00 cost-plus-fixed-fee contract aims to increase the test's sensitivity and shelf life, develop sustainable reagents, transition manufacturing to an automated line, and purchase two lots of approximately 10,000 improved tests. This is a sole-source...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...

This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Orasure Technologies Inc., a for-profit manufacturer of medical diagnostic products. The contract is for the development and production of the OraQuick Zika Point-of-Care Test, with a ceiling value of $4,969,092.67. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an ultimate completion date of June 30, 2019. This contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Orasure Technologies Inc., also known as Orasure, is a global company that specializes in the development, manufacture, and marketing of oral fluid diagnostic products and specimen collection devices. Through this and other federal contract awards, Orasure has provided a wide range of medical diagnostic products, including rapid tests for diseases such as HIV, Ebola, Hepatitis C, and COVID-19, as well as alcohol detection tests, to various government agencies. Orasure holds two significant indefinite delivery vehicles (IDVs) for supplying medical diagnostic products to federal agencies, with a potential value of $107.28 million from the Defense Logistics Agency Troop Support Medical and $6.38 million from the GSA Federal Supply Schedule 65-VII.

Generated 4/1/25, 7:45 PM